Trademark: 97052261
Word
AREXVY
Status
Registered
Status Code
700
Status Date
Tuesday, November 15, 2022
Serial Number
97052261
Registration Number
6899018
Registration Date
Tuesday, November 15, 2022
Mark Type
4000
Filing Date
Wednesday, September 29, 2021
Published for Opposition
Tuesday, August 30, 2022

Trademark Owner History
GlaxoSmithKline Biologicals SA - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Nov 15, 2022
Notice Of Registration Confirmation Emailed
Nov 15, 2022
Registered-Principal Register
Aug 30, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2022
Published For Opposition
Aug 10, 2022
Notification Of Notice Of Publication E-Mailed
Aug 2, 2022
Teas Change Of Correspondence Received
Aug 2, 2022
Teas Change Of Domestic Representatives Address
Aug 2, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 2, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 23, 2022
Approved For Pub - Principal Register
Jul 22, 2022
Preliminary/Voluntary Amendment - Entered
Jul 22, 2022
Assigned To Lie
Jul 5, 2022
Teas Voluntary Amendment Received
Jun 29, 2022
Assigned To Examiner
Oct 27, 2021
New Application Office Supplied Data Entered In Tram
Oct 2, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24